The current report hence shows the development of AAA in postmenopausal women from another hormonal perspective, leading to our hypothesis that follicle stimulating hormone (FSH) may enhance AAA onset or progression, via different mechanisms as outlined below. This evidence concerns the gene BRD2 and triple-A syndrome.